News
ISID Collegiality Awardee 2025
We are delighted to introduce the recipient of the 2025 ISID Collegiality Award for the JSID...
Congratulations to the Montagna Symposium travel awardees
Cristina de Guzman Strong, PhD Appointed Next Editor of JID Innovations
The Society for Investigative Dermatology (SID) and the European Society for Dermatologic...
Acknowledgements
The ESDR would like to extend its gratitude to the Scientific Committee Members, Local Organizing...
Welcoming the New ESDR Executive Team
We are pleased to introduce the newly formed ESDR Executive Team, Curdin CONRAD as President,...
Introducing our new ESDR Board Members
We are delighted to welcome our new ESDR Board members. Your expertise, fresh perspectives, and...
About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- Identification of UVB-induced TREM-1 positive tolerogenic DCs and TREM-1 signaling as a target in the prevention of UVB-induced immune suppression and skin carcinogenesis
- A Prospective Randomized Trial of Microneedle Radiofrequency Combined with Low-dose Isotretinoin vs. Isotretinoin Alone for Acne Vulgaris Treatment
- Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled trial
- Genetic and Clinical Insights into Inherited Erythromelalgia: A Comprehensive Review of Cases from China and Worldwide
- MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma via IL-17A Release
